Alnylam Pharmaceuticals
ALNY
#1148
Rank
NZ$36.22 B
Marketcap
NZ$270.47
Share price
-3.17%
Change (1 day)
-65.44%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company